KDx Diagnostics And Lister Hospital Announce The Launch Of A Non-Invasive URO17® Urine Test For Bladder Cancer In The United Kingdom
- Sunday, December 5, 2021, 7:15
- PR Newswire
- Add a comment
SAN JOSE, Calif. and STEVENAGE, England, Dec. 5, 2021 /PRNewswire/ — KDx Diagnostics, Inc. (KDx), and Lister Hospital (East and North Hertfordshire NHS Trust), Stevenage, UK, announced today the launch in the United Kingdom (UK) of KDx’s URO17® test for detection of bladder cancer. This…
About the Author
admin has written 20655 stories on this site.